We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
IT&E | LSE:ITEL | London | Ordinary Share | AU000000ITE8 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.125 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 4291C IT&e Limited 01 September 2008 1 September 2008 IT&e Limited Preliminary Results and Proposed De-listing from AIM Preliminary Final Results for the year ended 30 June 2008 IT&e Limited (ASX code: ITE, AIM: ITEL, "the Company") today released its preliminary final results for the year ended 30 June 2008. The Company will release its financial report prior to 30 September 2008. In releasing the result the Chairman, Ellis Bugg, said that the Board was disappointed to have to again report the Company was in an operating loss position. He noted however that despite the disappointing financial result, the RAZOR product is now implemented or being implemented in eight financial institutions and three exchanges around the world which gives the Board confidence in the future prospects for the Company. Business highlights of the year * Two new sales of RAZOR's Clearing House Risk Management System to LCH.Clearnet Group and a new US Clearing Organisation were secured. These sales, combined with the RAZOR solution provided for the Australian Stock Exchange, place the Company in a good position in the Central Counter-Party management market. * Selection by Calyon New York - RAZOR selected to support the requirements of the Bank's regulated AAA derivatives trading program. * Sale to a major UK financial institution of a RAZOR solution for management of economic capital. * Three successful implementation of RAZOR solutions: * * Royal Bank of Canada (RBC) - global rollout of RAZOR Credit Risk and Economic Capital modules. RBC can now use RAZOR to obtain a more accurate view of credit exposure and limit utilization across its trading business. * Man Group plc - implemented RAZOR's Economic Capital module. * Federal Home Loan Bank of Pittsburgh - implemented RAZOR Credit Risk & Limit Management modules. Factors impacting the loss * Delays in sales due to the difficult banking environment * The deferral of revenue recognition (in accordance with AASB 118) of the sign-on portion (USD$1m) of a Razor product license that was invoiced and paid prior to 30 June 2008 * Mutually agreed termination of a major joint development project as announced on 30 April 2008 * The resultant decrease in the discounted cash flow value of the NextSet/PTX asset requiring an impairment write-off Financial Summary $000 2008 2007 Revenue 13,084 11,791 Operating loss 4,545 5,700 Net loss after impairment 5,936 5,700 write-off (475) 1,791 Net tangible assets Outlook for the future Mr Bugg noted that the Company has affirmed that it should maintain its primary focus on the RAZOR product as it offers the greatest source of upside for stakeholders given its growing global reputation and client base and that should an opportunity emerge to sell non-strategic assets at an appropriate price this would be embraced. He also advised that the organisation's cost structure had already been scaled back by approximately $2.5m through reduced headcount and a tight control over all discretionary expenditure, and that the Board intends to seek shareholder approval at the annual general meeting to de-list from the AIM market of the London Stock Exchange. The Board, he confirmed, is committed to continuing to take steps needed to improve the financial performance of the Company and will further restructure the business as appropriate to better align future revenue and expenses. Extracts from the financial report for the year ended 30 June 2008 are set out below and a full copy of the financial report is available on the Company's website www.ite.com.au. Enquiries/Additional Information: IT&e Limited James Maranis, CEO: +61 2 9236 9427 Oliver Carton, Company Secretary: +61 412 149 118 Grant Thornton UK LLP Fiona Owen: +44 (0)20 7383 5100 Results for announcement to the market $A'000 Revenue and Net Profit before impairment of Goodwill Revenue from ordinary activities Up 10% to 13,138 Profit (loss) from ordinary activities Down 20.3% to (4,545) attributable to members Revenue and Net Profit Revenue from ordinary activities Up 10% to 13,138 Profit (loss) from ordinary activities Up 4% to (5,936) attributable to members Net profit (loss) for the period attributable Up 4% to (5,936) to members Dividends (distributions) Amount per security Franked amount per security Final dividend Nil Nil Interim dividend Previous corresponding period: Final dividend Nil Nil Interim dividend Date for determining entitlements to the N/A dividend Brief explanation of Revenue and Net Profit Revenue showed some improvement from F07 due to four new sales of RAZOR and three successful implementations but was lower than expected primarily as a consequence of: * Delays in sales due to the difficult banking environment * Deferral of recognition of the sign-on portion (US$1m) of a RAZOR product licence that was invoiced and paid prior to 30 June 2008 but will be recognised over several years in accordance with AASB 118 Revenue * The mutually agreed termination of a major joint NextSet/PTX development project as announced on 30 April 2008 * Lower services revenue reflecting a growing focus on the RAZOR product and related implementations. Operating loss before Goodwill Impairment was 23% lower than F07 primarily as a consequence of increased Razor product revenue. The significant loss was primarily due to revenues being lower than expected as explained above. Operating result including goodwill impairment was a loss higher than F07 as a consequence of the issues explained above and a NextSet/PTX goodwill impairment write-off of $1,391k following the termination of the NextSet/PTX major joint development project noted above. Signed by the Chairman ************** Ellis Bugg 31 August 2008 Consolidated Income Statement For the Financial Year ended 30 June 2008 Note CONSOLIDATED 2008 2007 $'000 $'000 License fees and services 13,084 11,791 Interest revenue 54 110 Revenue 5 13,138 11,901 Cost of sales (11,103) (10,527) Gross profit 2,035 1,374 Other income 5 131 151 Operating expenditure Marketing expenses (63) (52) Occupancy expenses (1,017) (790) Employee benefits expenses (1,469) (2,093) Administrative expenses (3,457) (3,347) Goodwill impairment 8 (1,391) - Other expenses (613) (576) Finance costs (12) (53) (Loss) before tax and share-based payments (5,856) (5,386) Share-based payment expense (53) (298) (Loss) before income tax (5,909) (5,684) Income tax expense (27) (16) Net (loss) for the period (5,936) (5,700) Basic and diluted earnings per share 6 (2.41) (2.74) (cents per share) Consolidated Balance Sheet As at 30 June 2008 Note CONSOLIDATED 2008 2007 $'000 $'000 ASSETS Current Assets Cash and cash equivalents 1,604 2,429 Trade and other receivables 1,905 2,248 Prepayments 120 102 Financial assets 341 62 Accrued revenue 962 339 Total Current Assets 4,932 5,180 Non-current Assets Financial assets 185 425 Property, plant and equipment 566 286 Goodwill 8 3,290 4,681 Investments in controlled entities - - Total Non-current Assets 4,041 5,392 TOTAL ASSETS 8,973 10,572 LIABILITIES Current Liabilities Trade and other payables 2,141 2,082 Current tax liabilities - 18 Provisions 847 761 Unearned revenue 2,410 968 Total Current Liabilities 5,398 3,829 Non-current Liabilities Deferred lease incentive 262 - Convertible Loan 164 - Provisions 333 271 Total Non-current Liabilities 759 271 TOTAL LIABILITIES 6,157 4,100 NET ASSETS 2,816 6,472 EQUITY Equity attributable to equity holders of the parent Contributed equity 9 52,212 49,273 (Accumulated losses) (52,714) (46,778) Reserves 3,318 3,977 TOTAL EQUITY 2,816 6,472 Consolidated Statement of Changes in Equity For the Financial Year ended 30 June 2008 CONSOLIDATED Issued capital Accumulated losses Other reserves Total $ '000 $ '000 $ '000 $ '000 At 1 July 2007 49,273 (46,778) 3,977 6,472 Net (loss) for the period - (5,936) - (5,936) Currency translation - - 87 87 differences Total recognised income and - (5,936) 87 (5,849) expense for the period Issue of share capital (note 2,140 - - 2,140 21) Share earn-out (note 21) 12 - (12) - Share-based payment (note 21) 5 - 48 53 Share payment Halcyon (note 782 - (782) - 21) Capital raising expenses (note - - - - 21) At 30 June 2008 52,212 (52,714) 3,318 2,816 CONSOLIDATED Issued capital Accumulated losses Other reserves Total $ '000 $ '000 $ '000 $ '000 At 1 July 2006 46,144 (41,078) 3,017 8,083 Net (loss) for the period - (5,700) - (5,700) Currency translation - - 240 240 differences Total recognised income and - (5,700) 240 (5,460) expense for the period Issue of share capital (note 3,900 - - 3,900 21) Share earn-out (note 21) 406 - (418) (12) Share-based payment (note 21) 9 - 289 298 Share payment Halcyon (note - - 824 824 21) Capital raising expenses (note (1,186) - 25 (1,161) 21) At 30 June 2007 49,273 (46,778) 3,977 6,472 Consolidated Cash Flow Statement For the Financial Year ended 30 June 2008 Note CONSOLIDATED 2008 2007 $'000 $'000 Cash flows from Operating Activities Receipts from customers (inclusive of GST) 13,264 13,918 Payments to suppliers and employees (inclusive of (15,839) (17,290) GST) Interest and other items of a similar nature 54 110 received ATO Tax Refund 41 - Government grant received 90 151 Income taxes paid (27) (16) Net cash flows used in operating activities 7 (2,417) (3,127) Cash flows from Investing Activities Payment of cash element for acquisitions - (1,224) Payments for property, plant and equipment (286) (149) Net cash flows used in investing activities (286) (1,373) Cash flows from Financing Activities Proceeds from issue of shares and options 2,140 3,900 Capital raising costs - (1,186) Net cash flows from/(used in) financing activities 2,140 2,714 Net increase/(decrease) in cash and cash (563) (1,786) equivalents Net foreign exchange differences (262) (34) Cash and cash equivalents at beginning of the 2,429 4,249 period Cash and cash equivalents at end of the period 1,604 2,429 This information is provided by RNS The company news service from the London Stock Exchange END FR FKDKBKBKDQCK
1 Year IT&E Chart |
1 Month IT&E Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions